Clinical delineation and natural history of the PIK3CA‐related overgrowth spectrum
Top Cited Papers
Open Access
- 29 April 2014
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 164 (7), 1713-1733
- https://doi.org/10.1002/ajmg.a.36552
Abstract
Somatic mutations in the phosphatidylinositol/AKT/mTOR pathway cause segmental overgrowth disorders. Diagnostic descriptors associated with PIK3CA mutations include fibroadipose overgrowth (FAO), Hemihyperplasia multiple Lipomatosis (HHML), Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, Scoliosis/skeletal and spinal (CLOVES) syndrome, macrodactyly, and the megalencephaly syndrome, Megalencephaly-Capillary malformation (MCAP) syndrome. We set out to refine the understanding of the clinical spectrum and natural history of these phenotypes, and now describe 35 patients with segmental overgrowth and somatic PIK3CA mutations. The phenotypic data show that these previously described disease entities have considerable overlap, and represent a spectrum. While this spectrum overlaps with Proteus syndrome (sporadic, mosaic, and progressive) it can be distinguished by the absence of cerebriform connective tissue nevi and a distinct natural history. Vascular malformations were found in 15/35 (43%) and epidermal nevi in 4/35 (11%) patients, lower than in Proteus syndrome. Unlike Proteus syndrome, 31/35 (89%) patients with PIK3CA mutations had congenital overgrowth, and in 35/35 patients this was asymmetric and disproportionate. Overgrowth was mild with little postnatal progression in most, while in others it was severe and progressive requiring multiple surgeries. Novel findings include: adipose dysregulation present in all patients, unilateral overgrowth that is predominantly left-sided, overgrowth that affects the lower extremities more than the upper extremities and progresses in a distal to proximal pattern, and in the most severely affected patients is associated with marked paucity of adipose tissue in unaffected areas. While the current data are consistent with some genotype–phenotype correlation, this cannot yet be confirmed. © The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals, Inc.Keywords
Funding Information
- Intramural Research Program of the National Human Genome Research Institute
- Wellcome Trust (Senior Research Fellowship in Clinical Science) (098498/Z/12/Z)
- Clinical Research Training Fellowship (097721/Z/11/Z)
- UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre
- UK Medical Research Council Centre for Obesity and Related Metabolic Diseases
This publication has 46 references indexed in Scilit:
- Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation inGNAQThe New England Journal of Medicine, 2013
- Somatic gain-of-function mutations in PIK3CA in patients with macrodactylyHuman Molecular Genetics, 2012
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CANature Genetics, 2012
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesNature Genetics, 2012
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES SyndromeAmerican Journal of Human Genetics, 2012
- Somatic Activation of AKT3 Causes Hemispheric Developmental Brain MalformationsNeuron, 2012
- A Mosaic Activating Mutation inAKT1Associated with the Proteus SyndromeThe New England Journal of Medicine, 2011
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersNature Medicine, 2008
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation patternProceedings of the National Academy of Sciences of the United States of America, 2007